HOME >> BIOLOGY >> NEWS
Four IU professors are 2004 Guggenheim Fellows

hopes the book will put to rest speculative and unsupported opinions about the nature of plant species as well as what types of evolutionary processes are likely to produce new species.

Beckwith, a world-renowned expert on Tibet, Nepal and other political entities in central Asia, will use his Guggenheim award to write a comprehensive history of central Eurasia.

Folklorist Brown plans to revisit and recast the beloved English and Scottish ballads written by 19th-century polymath Francis James Child.

Since 1925, the Guggenheim Foundation has granted about $228 million in fellowships to more than 15,000 Americans and U.S. resident aliens. Recent Guggenheim fellows among IU's total of 113 are biologist Rudolf Raff, poet Kevin Young and composer Claude Baker. IU has had at least one fellow each year since 1998.

Rieseberg also has been named to receive the first-ever Stebbins Medal by the Vienna, Austria-based International Association for Plant Taxonomy. The medal, which will be awarded at the May meeting of the International Organization of Plant Biosystematists in Valencia, Spain, recognizes the previous year's "outstanding article or book about plant systematics and evolution," according to IAPT secretary-treasurer Tod Stuessy. A committee of five professional plant evolutionary biologists awarded the honor to Rieseberg and coauthors of "Major ecological transitions in wild sunflowers facilitated by hybridization," published last year in the journal Science.


'"/>

Contact: David Bricker
brickerd@indiana.edu
812-856-9035
Indiana University
8-Apr-2004


Page: 1 2

Related biology news :

1. University of Minnesota professors to speak at symposium on international trade
2. UT Southwestern scientist awarded prestigious American Cancer Society research professorship
3. Nominations sought for professorship by the American Association for Cancer Research
4. Howard Hughes Medical Institutes million dollar professors
5. Washington Universitys Sarah C. R. Elgin is one of 20 million dollar professors
6. K-State professors make discovery in pesticide-resistant bugs
7. Five Rutgers professors named fellows of national science association
8. 20 scientists selected as Aldo Leopold Leadership Fellows
9. UC San Diego places in top tier of institutions awarded 2004 Sloan Research Fellowships
10. Ten Chinese reporters receive AAAS Fellowships
11. Crops society announces Pioneer Fellowship in Plant Sciences

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Four professors are Guggenheim Fellows

(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/25/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... of recent discussions with certain shareholders representing approximately 45% ... after dealing with certain matters including the appointment of ... on March 26, 2015 (the "Meeting") it intends to ... will take place when the Meeting reconvenes. The Meeting ...
(Date:3/25/2015)... 25, 2015  S&P Capital IQ (MHFI) announced ... Report coverage on Abattis Bioceuticals Corp . ... is a specialty biotechnology company with capabilities through ... marketing proprietary ingredients, bio-similar compounds, patented equipment and ... North America . The company seeks to ...
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... NextCODE, which provides comprehensive capabilities for using the genome to ... on their publication of the largest studies of whole-genome data ... online in Nature Genetics – are ... sequence variation, authored by a team of deCODE scientists led ...
(Date:3/25/2015)... CA (PRWEB) March 25, 2015 ... for Novel Mechanism of Action in Neuromuscular Diseases ... 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the ... skeletal muscle troponin activator tirasemtiv in the journal ... Phase IIa “Evidence of Effect” or hypothesis-generating clinical ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: